GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Functional Anorectal Pain
Functional GI

Functional Anorectal Pain

Levator ani, unspecified pain and proctalgia fugax

Proctalgia fugax additionally requires the pain to be unrelated to defecation and completely absent between episodes.

The single examination finding that separates levator ani syndrome from unspecified functional anorectal pain. It requires a deliberate digital examination with posterior traction — not part of a routine rectal examination.

Three disorders separated by two questions: how long the episodes last, and whether the puborectalis is tender on traction. Episodes of 30 minutes or longer with tenderness is levator ani syndrome; without tenderness it is unspecified; seconds to under 30 minutes is proctalgia fugax.

When to use
Use it in a patient with rectal or anal pain once structural disease has been looked for and not found. The criteria are most valuable at two moments: when the examination is being planned, because the discriminating physical sign is elicited only by a specific manoeuvre that is easy to omit, and when the patient asks what the pain is, because a named diagnosis with a known benign course changes the consultation considerably.
Why use it
Because the distinction is not academic — it predicts response to treatment. Levator ani syndrome, defined by puborectalis tenderness, responds to biofeedback in a way that the unspecified variant does not; that difference was demonstrated in a randomised trial and is the reason Rome IV split what had previously been one category. Proctalgia fugax is entirely separate: episodes are so brief that they are usually over before any treatment could work, and the useful intervention is explanation and reassurance rather than therapy. Getting the category right therefore determines whether you offer biofeedback, offer reassurance, or keep looking for structural disease.
Formula, evidence and interpretation

About the Rome IV Criteria for Functional Anorectal Pain

Three disorders separated by two questions. First, how long does an episode last? Thirty minutes or longer means chronic pain — levator ani syndrome or its unspecified variant. Seconds to at most 30 minutes, with complete freedom from pain between episodes, means proctalgia fugax. Second, for the chronic group only: is there tenderness on posterior traction of the puborectalis on digital examination? Tenderness present gives levator ani syndrome; absent gives unspecified functional anorectal pain. All three require exclusion of structural causes — inflammatory bowel disease, abscess, fissure, thrombosed haemorrhoids, prostatitis, coccygodynia and major structural alterations of the pelvic floor.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Chronic (episodes ≥ 30 min, 3 months of symptoms, onset ≥ 6 months, structural causes excluded): tenderness on posterior traction of puborectalis → F2a levator ani syndrome no tenderness → F2b unspecified functional anorectal pain Episodic (seconds to ≤ 30 min, no pain between episodes, unrelated to defecation, structural causes excluded): → F2c proctalgia fugax
30 minutes
The single number that separates chronic from episodic. It appears twice — as the minimum for the chronic disorders and as the maximum for proctalgia fugax — so the two categories meet exactly and do not overlap.
Posterior traction on the puborectalis
A specific manoeuvre, not routine digital examination. It is the only feature separating F2a from F2b and therefore the only feature predicting biofeedback response.
No pain between episodes
Required for proctalgia fugax. Background pain between attacks moves the patient into the chronic group even if the attacks themselves are brief.
  • Proctalgia fugax is explicitly unrelated to defecation — pain during or after defecation suggests fissure or another structural cause.
  • Rome IV requires the chronic disorders to satisfy the usual three-month/six-month timing rule; proctalgia fugax is defined by pattern instead.
  • The exclusion list is specific and named: inflammatory bowel disease, intramuscular abscess, anal fissure, thrombosed haemorrhoids, prostatitis, coccygodynia and major structural alterations of the pelvic floor.
  • F2b exists so that patients without the physical sign are not given a diagnosis that implies a treatment which does not work for them.

Interpreting the result

A diagnosis of levator ani syndrome should lead to biofeedback, which has randomised evidence of benefit in exactly this group and outperformed both electrogalvanic stimulation and digital massage. Unspecified functional anorectal pain carries no such evidence; management is symptomatic and expectations should be set accordingly, and it is worth periodically reconsidering whether a structural or neuropathic cause has been missed. Proctalgia fugax needs explanation more than treatment — episodes are typically too short for any intervention to act within them, the condition is benign, and patients are frequently relieved simply to learn it has a name and is recognised. Where attacks are frequent or severe enough to warrant it, inhaled salbutamol has limited evidence in that setting. In all three, revisit the exclusion list if the pattern changes, particularly if pain becomes related to defecation, if bleeding appears, or if systemic features develop.

ScoreBandWhat it meansAction
F2a — Levator ani syndromeChronic pain with puborectalis tendernessEpisodes ≥ 30 minutes, tenderness on posterior traction of the puborectalisBiofeedback — the only phenotype with randomised evidence of benefit
F2b — Unspecified functional anorectal painChronic pain without the physical signMeets levator ani criteria in every respect except puborectalis tendernessSymptomatic management; biofeedback evidence does not extend here; periodically reconsider structural causes
F2c — Proctalgia fugaxBrief episodic painSeconds to at most 30 minutes, unrelated to defecation, no pain between episodesExplanation and reassurance; episodes are usually over before treatment could act
Criteria not metCriteria not metStructural cause present, timing not satisfied, or pattern does not fitRe-examine for fissure, abscess, thrombosed haemorrhoids, prostatitis or coccygodynia

What the Functional Anorectal Pain needs (6 inputs)

Chronic or recurrent rectal pain
The presenting symptom common to all three. Location is rectal or anal rather than perineal or coccygeal, which points elsewhere.
Episode duration — 30 minutes or longer
Defines the chronic group: levator ani syndrome or unspecified functional anorectal pain. Often described as a constant dull ache or pressure, frequently worse on sitting.
Episode duration — seconds to at most 30 minutes
Defines proctalgia fugax. Episodes are brief, often nocturnal, unrelated to defecation, and there is no pain at all between episodes.
Tenderness on posterior traction of the puborectalis
The discriminating physical sign in the chronic group. Elicited by digital examination with posterior traction on the puborectalis muscle — not by simple digital examination, and easily missed if the manoeuvre is not performed deliberately.
Exclusion of structural and other causes
Required for all three: inflammatory bowel disease, intramuscular abscess, anal fissure, thrombosed haemorrhoids, prostatitis, coccygodynia and major structural alterations of the pelvic floor.
Symptom duration — 3 months, onset at least 6 months ago
The standard Rome IV timing rule, applied to the chronic disorders. Proctalgia fugax is defined by episode pattern rather than by a duration threshold.

What it returns

Which of the three disorders is met
Levator ani syndrome, unspecified functional anorectal pain, or proctalgia fugax — or none.
Whether the biofeedback-responsive phenotype is present
Only levator ani syndrome, defined by puborectalis tenderness, has trial evidence of benefit from biofeedback.

How it is calculated

Rome IV separates these three disorders on the basis of what actually distinguishes them clinically rather than on any theory of mechanism. The chronic/episodic split at 30 minutes reflects two genuinely different clinical pictures: a persistent ache that patients relate to sitting and that dominates their day, versus sudden severe attacks that are over before anything can be done and that often wake the patient at night. The tenderness sign then subdivides the chronic group, and it does so for an empirical reason. A randomised trial comparing biofeedback, electrogalvanic stimulation and massage found that biofeedback was superior — but the benefit was seen in patients with puborectalis tenderness, not in those without. Rome IV encoded that finding into the criteria by making the sign the dividing line, which is why the unspecified category exists at all: it identifies patients for whom the evidence does not support the treatment.

Facts & figures

Separating the three disorders
FeatureLevator ani (F2a)Unspecified (F2b)Proctalgia fugax (F2c)
Episode duration≥ 30 minutes≥ 30 minutesSeconds to ≤ 30 minutes
Pain between episodesOften continuous acheOften continuous acheNone — complete freedom
Puborectalis tenderness on tractionPresentAbsentNot part of the definition
Relation to defecationNot requiredNot requiredExplicitly unrelated
Typical timingWorse on sitting, daytimeWorse on sitting, daytimeOften nocturnal, wakes the patient
Evidence-based treatmentBiofeedbackNone establishedReassurance; salbutamol if severe

The only feature separating F2a from F2b is the physical sign — which is why the examination manoeuvre matters more here than in most functional diagnoses.

Evidence

Derivation — Rome Foundation, anorectal disorders committee

2016

Consensus criteria from the Rome IV anorectal disorders committee, published in Gastroenterology in 2016.

Rome IV introduced the split between levator ani syndrome and unspecified functional anorectal pain, using puborectalis tenderness as the dividing line specifically because that feature predicted response to biofeedback in randomised data.

Randomised trial — biofeedback in chronic proctalgia

2010

Randomised comparison of biofeedback, electrogalvanic stimulation and digital massage in patients with chronic proctalgia, reported by Chiarioni and colleagues in 2010.

Biofeedback was superior to both comparators, with benefit concentrated in patients who had tenderness on puborectalis traction — the finding that Rome IV subsequently built into the diagnostic criteria.

Guideline adoption — ACG 2021

2021

ACG clinical guideline on the management of benign anorectal disorders.

Endorses biofeedback for levator ani syndrome and reflects the Rome IV separation of the chronic disorders by physical sign.

How it compares

Functional Anorectal Pain vs Centrally mediated abdominal pain syndrome

Different site, different mechanism — but the same trap of escalating investigation in the absence of structural disease.

CAPS describes continuous or near-continuous abdominal pain with central features — loss of relation to gut events, and behavioural and psychosocial characteristics that dominate the picture. Functional anorectal pain is localised to the rectum or anus and, in the case of levator ani syndrome, has a reproducible physical sign and a treatment that works. The practical overlap is in management style: in both, repeated imaging and endoscopy after a negative work-up tends to entrench the problem, and a confident positive diagnosis is part of the treatment.

Open the Centrally mediated abdominal pain syndrome calculator →

Functional Anorectal Pain vs Functional defecation disorders

Both are pelvic floor disorders treated with biofeedback, but one is defined by pain and the other by impaired evacuation.

Functional defecation disorders require objective evidence of impaired evacuation — abnormal balloon expulsion, manometry or imaging — in a patient who also meets criteria for functional constipation or IBS with constipation. Functional anorectal pain requires pain and, for levator ani syndrome, tenderness on puborectalis traction. They can coexist, and both respond to biofeedback, though the retraining targets differ: coordination of evacuation in one, and relaxation of a chronically contracted pelvic floor in the other. A patient with both should be assessed with anorectal manometry, which addresses each question in the same study.

Open the Functional defecation disorders calculator →

Functional Anorectal Pain vs Faecal incontinence

Opposite symptoms from the same anatomical region — and both are under-disclosed for the same reason.

Rome IV groups anorectal pain and faecal incontinence in the same chapter because they share anatomy and assessment pathway, not because they resemble each other. Both are examined with digital rectal examination and anorectal physiology, and both are treated conservatively before anything invasive is considered. What they most share is that patients rarely raise either spontaneously, so both need to be asked about directly rather than waited for.

Open the Faecal incontinence calculator →Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal Disorders. Gastroenterology. 2016;150(6):1430-1442.

Pearls & pitfalls

  • Perform posterior traction on the puborectalis deliberately — routine digital examination will not elicit the sign, and the sign is the diagnosis.
  • Thirty minutes is the dividing line and it appears twice: minimum for chronic disorders, maximum for proctalgia fugax. The categories meet exactly.
  • Complete freedom from pain between attacks is required for proctalgia fugax. Background ache moves the patient into the chronic group.
  • Proctalgia fugax is explicitly unrelated to defecation — pain on defecation points to a fissure.
  • The unspecified category is not a lesser diagnosis; it identifies patients for whom biofeedback lacks evidence, which is useful information.
  • Work through the named exclusions specifically: inflammatory bowel disease, intramuscular abscess, fissure, thrombosed haemorrhoids, prostatitis, coccygodynia, major pelvic floor structural change.
  • Perineal or coccygeal rather than rectal pain suggests coccygodynia or a pudendal neuropathy, not these disorders.
  • Proctalgia fugax episodes are often nocturnal and wake the patient; this is characteristic rather than alarming.
  • Reassess if the pattern changes — new bleeding, defecation-related pain or systemic features send you back to the exclusion list.
  • For proctalgia fugax, explanation is the intervention; most patients have assumed something serious was being missed.

Critical actions

  • Take a careful history of episode duration, since it alone assigns the patient to the chronic or episodic group.
  • Ask specifically whether there is any pain between episodes — this is what distinguishes proctalgia fugax from chronic pain with brief exacerbations.
  • Perform a digital rectal examination with deliberate posterior traction on the puborectalis and record whether tenderness is present.
  • Inspect for anal fissure and thrombosed haemorrhoids, which are common and easily treated.
  • Exclude intramuscular abscess, inflammatory bowel disease and prostatitis where the history suggests them.
  • Consider coccygodynia and pudendal neuralgia where the pain is not clearly rectal.
  • Offer biofeedback where levator ani syndrome is diagnosed, and refer to a service that provides it.
  • For proctalgia fugax, explain the benign natural history explicitly and avoid escalating investigation without new features.
  • Document which of the three diagnoses applies, since the treatment implication differs materially between them.

Why this score exists

Most diagnostic criteria divide patients by symptom; this one divides them by a physical sign, and that choice is unusual enough to be worth noticing. Rome IV could have kept chronic proctalgia as a single entity — the symptoms are identical either side of the line. It split them because a trial showed that the treatment worked in one group and not the other, and the only thing separating those groups was tenderness on posterior traction of the puborectalis. The consequence is that an examination manoeuvre most clinicians do not routinely perform determines which of two diagnoses a patient receives, and whether the one treatment with randomised support is offered. It is a rare instance of criteria being written backwards from a therapeutic result, and it means the examination is not confirmatory here — it is the diagnosis.

About the creator

  • Satish S. C. Rao

    First author, Rome IV anorectal disorders committee

    Chaired the committee that produced the Rome IV anorectal disorder criteria.

  • Giuseppe Chiarioni

    Co-author; lead author of the randomised biofeedback trial in chronic proctalgia

    His trial produced the tenderness-response finding that Rome IV encoded as the F2a/F2b division.

  • William E. Whitehead

    Co-author; anorectal disorders and biofeedback research

    Contributed to both the trial evidence and the Rome IV criteria for this group.

Limitations

  • The discriminating sign — tenderness on puborectalis traction — is subjective and its reproducibility between examiners has not been well quantified.
  • The 30-minute cut-off is a consensus convention rather than a measured threshold, and patients rarely time their episodes.
  • No treatment has established evidence in unspecified functional anorectal pain, so that diagnosis names a group without offering a route forward.
  • Consensus-derived criteria with no measured sensitivity or specificity against an objective standard.
  • The exclusion list requires a reasonably thorough work-up, which the criteria themselves do not specify.
  • Proctalgia fugax is defined by pattern rather than duration of illness, so it cannot be dated or staged.
  • Pudendal neuralgia is not named in the exclusion list but is a genuine differential for chronic anorectal pain.
  • The criteria say nothing about frequency, so a patient with two episodes a year and one with daily episodes receive the same label.

If you are the patient

Pain in the back passage that has been investigated and found not to be caused by piles, a tear, an infection or inflammation is given one of three names, depending on the pattern. If the pain lasts half an hour or more at a time — often a dull ache or pressure that is worse when sitting — it is called levator ani syndrome or, if a particular tender spot is not found on examination, unspecified anorectal pain. If instead you get sudden sharp attacks lasting seconds to a few minutes, often at night, with no pain at all in between, that is proctalgia fugax. The examination matters more than usual here. Your doctor will press in a specific way on a muscle called the puborectalis, and whether that is tender decides which diagnosis applies — and whether a treatment called biofeedback, which retrains the pelvic floor muscles and has good evidence in that group, is likely to help you. Proctalgia fugax is different. The attacks are usually over before any treatment could work, and there is nothing dangerous about them; most people find it a relief simply to know the condition is recognised, has a name, and does not lead to anything worse. It is worth mentioning if things change — particularly bleeding, or pain that becomes linked to opening your bowels — because that would prompt another look.

Frequently asked questions

What are the Rome IV criteria for functional anorectal pain?#

Chronic or recurrent rectal pain with structural causes excluded, split three ways. Episodes lasting 30 minutes or longer with tenderness on posterior traction of the puborectalis is levator ani syndrome; the same picture without that tenderness is unspecified functional anorectal pain; episodes of seconds to at most 30 minutes with no pain in between and no relation to defecation is proctalgia fugax.

What is the difference between levator ani syndrome and unspecified functional anorectal pain?#

One physical sign. Both have identical symptoms — chronic rectal pain lasting 30 minutes or more per episode. Levator ani syndrome has tenderness on posterior traction of the puborectalis; the unspecified variant does not. Rome IV made this the dividing line because a randomised trial found that biofeedback benefited the tender group and not the other, so the distinction determines whether the one treatment with evidence is offered.

How is proctalgia fugax different?#

By duration and by what happens between attacks. Episodes last seconds to at most 30 minutes, are unrelated to defecation, and there is complete freedom from pain in between — that last point is what separates it from chronic pain with brief flares. Attacks are often nocturnal. They are typically over before any treatment could take effect, so management is explanation rather than therapy.

What must be excluded first?#

Rome IV names them specifically: inflammatory bowel disease, intramuscular abscess, anal fissure, thrombosed haemorrhoids, prostatitis, coccygodynia and major structural alterations of the pelvic floor. Anal fissure and thrombosed haemorrhoids are the common ones and are found on inspection, so examination does most of the work here.

What treatment works?#

Biofeedback, in levator ani syndrome specifically. A randomised trial found it superior to both electrogalvanic stimulation and digital massage, with the benefit concentrated in patients with puborectalis tenderness. No treatment has established evidence in the unspecified variant. For proctalgia fugax, reassurance is the mainstay, with inhaled salbutamol having limited evidence where attacks are frequent and severe.

Why does the examination matter so much?#

Because it is the only thing separating two diagnoses with identical symptoms and different treatment implications. Posterior traction on the puborectalis is a specific manoeuvre and is not part of a routine digital examination — omitting it means the distinction cannot be made, and a patient who would respond to biofeedback may not be offered it.

Is proctalgia fugax serious?#

No. It is benign, does not progress, and does not lead to other conditions. The severity of individual attacks often convinces patients otherwise, which is why explanation is genuinely therapeutic here. Reassessment is warranted only if the pattern changes — pain becoming related to defecation, new bleeding, or systemic features.

Do the timing rules apply to all three disorders?#

Not identically. The chronic disorders follow the standard Rome IV rule — criteria fulfilled for three months with onset at least six months previously. Proctalgia fugax is defined by its episode pattern rather than by a duration threshold, so it can be diagnosed without waiting out a qualifying period.

Related calculators

  • Functional Defecation Disorders — Rome IV — dyssynergia and inadequate propulsion
  • Faecal Incontinence (Rome IV) — Rome IV — the criteria, and why nobody is asked
  • Centrally Mediated Abdominal Pain (CAPS) — Rome IV — continuous pain unrelated to gut events
  • Functional Constipation — Rome IV — two of six items, IBS excluded
  • Rome IV Criteria for IBS — Irritable bowel syndrome diagnosis and subtype

References

Original / primary reference

  1. Rao SSC, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, Wald A. Anorectal Disorders. Gastroenterology. 2016;150(6):1430-1442 (Rome IV).

Validation and treatment evidence

  1. Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138(4):1321-1329.

Clinical practice guidelines

  1. Wald A, Bharucha AE, Limketkai B, Malcolm A, Remes-Troche JM, Whitehead WE, Rao SSC. ACG Clinical Guidelines: Management of Benign Anorectal Disorders. Am J Gastroenterol. 2021;116(10):1987-2008.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.